Browse Drug Recalls
855 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 855 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 855 FDA drug recalls in NC.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Feb 7, 2023 | Phenylephrine Hydrochloride Injection, USP 10 mg/mL Rx Only, 1 mL Single Dose... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | Rosuvastatin Tablets, USP 20 mg* Rx Only, Packaged as: a) 90-count bottle ND... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | Doxazosin Tablets USP 1 mg, Rx Only, Packaged as: a) 100-count bottle NDC 167... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | Doxazosin Tablets USP, 8 mg, Rx Only, Packaged in: a) 100 Tablets NDC 16729-4... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | Pravastatin Sodium Tablets USP, 40 mg, Rx Only, 1,000-count bottle Manufactur... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | Tadalafil Tablets, USP, 2.5 mg Rx Only, Packaged as: a) 30-count bottle NDC ... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | Finasteride Tablets USP 1 mg, 90-count bottle, Keeps, Rx Only, Manufactured f... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | Simvastatin Tablets USP 40 mg Rx Only, Packaged as: a) 90-count tablets NDC 1... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | Aripiprazole Tablets, USP 15 mg Rx Only, Packaged as: a) 30-count bottle NDC ... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | Glimepiride Tablets USP, 1 mg, Rx Only, Packaged in: a) 100-count bottle NDC... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | Aripiprazole Tablets, USP 10 mg Rx Only, Packaged as a) 30-count bottle, NDC ... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | Tadalafil Tablets, USP 10 mg Rx Only, Packaged as: a) 30-count bottle NDC 1... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | Glycopyrrolate Injection, USP 1 mg/5 mL (0.2 mg/mL) 5 mL Multiple Dose Vial, ... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | Pravastatin Sodium Tablets USP, 80 mg, Rx Only, 90- count bottle, Manufacture... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | Atorvastatin Calcium Tablets USP, 10 mg* Rx Only, Packaged as a) 90 Tablets ... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | BusPIRone Hydrochloride Tablets USP, 5 mg, Rx Only, Packaged as: a) 100 Table... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | rOPINIRole Tablets USP 0.25 mg*, 100-count bottle, Rx Only, Manufactured for:... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | Pirfenidone Tablets 267 mg 90-count bottle x3/Carton, Rx Only, Manufactured f... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | Atorvastatin Calcium Tablets USP 40 mg* Rx Only, Packaged as a) 90 Tablets ND... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | Montelukast Sodium Tablets, USP, 10 mg* Rx Only, Packaged as: a) 30-count bot... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | BusPIRone Hydrochloride Tablets USP 30 mg, 60-count bottle, Rx Only, Manufact... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | Atorvastatin Calcium Tablets USP 80 mg* Rx Only, Packaged as a) 90 Tablets ND... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | Dofetilide Capsules 250 mcg (0.25 mg) 60-count bottle, Rx only, Manufactured ... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Jan 12, 2023 | Allopurinol Tablets USP, 100 mg, 100-count bottle, Rx Only, Manufactured for:... | Presence of Foreign Substance: Presence of a small piece of green plastic embedded in the crack t... | Class II | Accord Healthcare, Inc. |
| Nov 29, 2022 | Daptomycin for Injection 350 mg/vial 1 Single-dose vial, Rx only, Manufacture... | Labeling mixup: cartons labeled as Daptomycin 350 mg/vial were found to contain vials of Daptomyc... | Class I | Accord Healthcare, Inc. |
| Nov 28, 2022 | 8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL) 50 mL Single D... | Defective Container: Complaints received of vial breakage and glass flying when pressurized while... | Class I | Exela Pharma Sciences LLC |
| Nov 28, 2022 | 8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL) 50 mL Single D... | Defective Container: Complaints received of vial breakage and glass flying when pressurized while... | Class I | Exela Pharma Sciences LLC |
| Oct 4, 2022 | 8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL) 50 mL Single D... | Defective Container: Complaints received of vial breakage and glass flying when pressurized while... | Class I | Exela Pharma Sciences LLC |
| Oct 4, 2022 | 8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL) 50 mL Single D... | Defective Container: Complaints received of vial breakage and glass flying when pressurized while... | Class I | Exela Pharma Sciences LLC |
| Jun 9, 2022 | Clonidine Transdermal System, USP 0.3 mg/day, 4 Patches (NDC 51862-455-01) pe... | Defective Delivery System: Out of specification for release liner removal force results at the 3... | Class II | Mayne Pharma Inc |
| May 13, 2022 | Tivicay (dolutegravir) Tablets 50 mg, 30-count Bottle, Rx Only, Manufactured ... | Labeling: incorrect or missing lot and/or expiration date. An incorrect expiration date was print... | Class III | GlaxoSmithKline LLC |
| Apr 27, 2022 | Open Nature Cough Drops Menthol-Cough Suppressant/Oral Anesthetic Peppermint ... | Subpotent drug: Low OOS for menthol content at the three month room temperature. | Class III | Bestco LLC |
| Jan 14, 2022 | Lexette (halobetasol propionate) Topical Foam, 0.05% 50 g canisters, Rx ONLY,... | CGMP Deviation: Difficulty dispensing/does not dispense or dispensing liquid instead of foam. | Class II | Mayne Pharma Inc |
| Jan 11, 2022 | 8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL), 50 mL vials, ... | Lack of Assurance of Sterility | Class II | Exela Pharma Sciences LLC |
| Aug 18, 2021 | X RATED HONEY FOR MEN, packaged in 15g packets, 4 packets per box, UPC 6 1368... | Marketed without an approved NDA/ANDA: Product found to be tainted with Tadalafil. | Class I | Phe Inc |
| Mar 10, 2021 | heal the world, moisturizing original hand sanitizer, Non-Sterile Solution, A... | Labeling Not Elsewhere Classified: Hand sanitizer packaged in containers resembling drinking wate... | Class I | PNHC, LLC. |
| Jan 28, 2021 | Glycopyrrolate Injection, USP 0.4 mg/2 mL (0.2 mg/mL) 25 x 2 mL Single Dose V... | Labeling; Label Mix-up; correctly labeled 2 mL vials were packaged into blister strips labeled fo... | Class III | Accord Healthcare, Inc. |
| Jan 21, 2021 | Lidocaine/Tetracaine (LIPO110)* 23%/7% Ointment 100 GMS per 4 ounce plastic o... | Superpotent Drug. Lidocaine higher concentration than listed | Class II | Stanley Specialty Pharmacy Compounding and Well... |
| Dec 9, 2020 | Vumerity (diroximel fumarate) delayed-release capsule, 231 mg, packaged in a... | Failed dissolution specifications: out-of-specification test results observed during the buffer s... | Class II | Biogen MA Inc. |
| Aug 7, 2020 | Always Be Clean Hand Sanitizer (73% Alcohol) 0.04 FL OZ (1.2 mL) packaged in ... | Labeling Not Elsewhere Classified: Product labeled to contain methanol | Class II | Open Book Extracts |
| Aug 7, 2020 | Just Hand Sanitizer (Ethyl Alcohol 73%) Single Use-Packs 100-count NDC 78065-... | Labeling Not Elsewhere Classified: Product labeled to contain methanol | Class II | Open Book Extracts |
| Aug 6, 2020 | Hydromorphone HCl 1 mg/mL 250 mL bags, Rx only, Family Pharmacy of Statesvill... | Lack of Assurance of Sterility | Class II | Family Pharmacy of Statesville |
| Aug 6, 2020 | Trimix (Alprostadil/Papaverine/Phentolamine) 20 mcg/30 mg/0.5 mg Injectable 5... | Lack of Assurance of Sterility | Class II | Family Pharmacy of Statesville |
| Aug 6, 2020 | Vancomycin14 mg/mL Fortified Ophthalmic Solution in 5 mL bottles, Rx only, Fa... | Lack of Assurance of Sterility | Class II | Family Pharmacy of Statesville |
| Aug 6, 2020 | Hydromorphone HCl 5 mg/mL Infusion in 250 mL bags, Rx only, Family Pharmacy o... | Lack of Assurance of Sterility | Class II | Family Pharmacy of Statesville |
| Aug 6, 2020 | Hydromorphone HCl 0.1 mg/mL Infusion in 1000 mL bags, Rx only, Family Pharmac... | Lack of Assurance of Sterility | Class II | Family Pharmacy of Statesville |
| Aug 6, 2020 | Hydromorphone HCl 2 mg/mL Infusion 250 mL bags, Rx only, Family Pharmacy of S... | Lack of Assurance of Sterility | Class II | Family Pharmacy of Statesville |
| Aug 6, 2020 | Ketamine 50 mg Infusion (LV 1) Solution in 250 mL bags, Rx only, Family Pharm... | Lack of Assurance of Sterility | Class II | Family Pharmacy of Statesville |
| Aug 6, 2020 | Morphine Sulfate 6 mg/mL Infusion in 250 mL bag, Rx only, Family Pharmacy of... | Lack of Assurance of Sterility | Class II | Family Pharmacy of Statesville |
| Aug 6, 2020 | Fentanyl 150 mcg/mL Infusion Solution in 250 mL bags, Rx only, Family Pharmac... | Lack of Assurance of Sterility | Class II | Family Pharmacy of Statesville |
Frequently Asked Questions
When a drug safety issue is identified, through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks, the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.